Who Generates Higher Gross Profit? Bio-Techne Corporation or HUTCHMED (China) Limited

A Tale of Two Companies: Bio-Techne vs. HUTCHMED

In the competitive landscape of biotechnology, Bio-Techne Corporation and HUTCHMED (China) Limited have been vying for dominance in gross profit generation since 2014. Over the years, Bio-Techne has consistently outperformed HUTCHMED, with its gross profit growing by approximately 206% from 2014 to 2023. In contrast, HUTCHMED's gross profit surged by an impressive 2,195% during the same period, albeit from a much smaller base.

Bio-Techne's steady growth reflects its robust market strategies and product innovations, peaking in 2023 with a gross profit nearly 70% higher than its 2014 figures. Meanwhile, HUTCHMED's remarkable growth trajectory, especially in recent years, highlights its expanding footprint in the biotech sector, despite a significant gap remaining between the two companies. As we look to the future, the question remains: can HUTCHMED close the gap, or will Bio-Techne continue to lead the charge?